AAAAAA
Results: 1-25/44
Authors:
Anichtchik, OV
Peitsaro, N
Rinne, JO
Kalimo, H
Panula, P
Citation: Ov. Anichtchik et al., Distribution and modulation of histamine H-3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease, NEUROBIOL D, 8(4), 2001, pp. 707-716
Authors:
Rinne, JO
Nurmi, E
Ruottinen, HM
Bergman, J
Eskola, O
Solin, O
Citation: Jo. Rinne et al., [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease, SYNAPSE, 40(3), 2001, pp. 193-200
Authors:
Nurmi, E
Ruottinen, HM
Bergman, J
Haaparanta, M
Solin, O
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study, MOVEMENT D, 16(4), 2001, pp. 608-615
Authors:
Jaaskelainen, SK
Rinne, JO
Forssell, H
Tenovuo, O
Kaasinen, V
Sonninen, P
Bergman, J
Citation: Sk. Jaaskelainen et al., Role of the dopaminergic system in chronic pain - a fluorodopa-PET study, PAIN, 90(3), 2001, pp. 257-260
Authors:
Bruck, A
Portin, R
Lindell, A
Laihinen, A
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: A. Bruck et al., Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus, NEUROSCI L, 311(2), 2001, pp. 81-84
Authors:
Lee, MS
Lyoo, CH
Ulmanen, I
Syvanen, AC
Rinne, JO
Citation: Ms. Lee et al., Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease, NEUROSCI L, 298(2), 2001, pp. 131-134
Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing
Authors:
Kemppainen, N
Marjamaki, P
Roytta, M
Rinne, JO
Citation: N. Kemppainen et al., Different pattern of reduction of striatal dopamine reuptake sites in Alzheimer's disease and ageing, J NEURAL TR, 108(7), 2001, pp. 827-836
Authors:
Tuominen, S
Juvonen, V
Amberla, K
Jolma, T
Rinne, JO
Tuisku, S
Kurki, T
Marttila, R
Poyhonen, M
Savontaus, ML
Viitanen, M
Kalimo, H
Citation: S. Tuominen et al., Phenotype of a homozygous CADASIL patient in comparison to 9 age-matched heterozygous patients with the same R133C Notch3 mutation, STROKE, 32(8), 2001, pp. 1767-1774
Authors:
Aberg, LE
Rinne, JO
Rajantie, I
Santavuori, P
Citation: Le. Aberg et al., A favorable response to antiparkinsonian treatment in juvenile neuronal ceroid lipofuscinosis, NEUROLOGY, 56(9), 2001, pp. 1236-1239
Authors:
Kaasinen, V
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Sonninen, P
Rinne, JO
Citation: V. Kaasinen et al., Personality traits and brain dopaminergic function in Parkinson's disease, P NAS US, 98(23), 2001, pp. 13272-13277
Authors:
Kaasinen, V
Nurmi, E
Bruck, A
Bergman, J
Solin, O
Rinne, JO
Citation: V. Kaasinen et al., Increased frontal [F-18]fluorodopa uptake in early Parkinson's Disease: sex differences in the prefrontal cortex, BRAIN, 124, 2001, pp. 1125-1130
Authors:
Kaasinen, V
Nagren, K
Hietala, J
Farde, L
Rinne, JO
Citation: V. Kaasinen et al., Sex differences in extrastriatal dopamine D-2-like receptors in the human brain, AM J PSYCHI, 158(2), 2001, pp. 308-311
Authors:
Mattila, PM
Roytta, M
Lonnberg, P
Marjamaki, P
Helenius, H
Rinne, JO
Citation: Pm. Mattila et al., Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment, ACT NEUROP, 102(2), 2001, pp. 160-166
Authors:
Lee, MS
Rinne, JO
Marsden, CD
Citation: Ms. Lee et al., The pedunculopontine nucleus: Its role in the genesis of movement disorders, YONSEI MED, 41(2), 2000, pp. 167-184
Authors:
Nurmi, E
Ruottinen, HM
Kaasinen, V
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: E. Nurmi et al., Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT, ANN NEUROL, 47(6), 2000, pp. 804-808
Authors:
Laihinen, A
Ruottinen, H
Rinne, JO
Haaparanta, M
Bergman, J
Solin, O
Koskenvuo, M
Marttila, R
Rinne, UK
Citation: A. Laihinen et al., Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET, J NEUROL, 247, 2000, pp. 110-113
Authors:
Rinne, JO
Tommola, J
Laine, M
Krause, BJ
Schmidt, D
Kaasinen, V
Teras, M
Sipila, H
Sunnari, M
Citation: Jo. Rinne et al., The translating brain: cerebral activation patterns during simultaneous interpreting, NEUROSCI L, 294(2), 2000, pp. 85-88
Authors:
Mattila, KM
Axelman, K
Rinne, JO
Blomberg, M
Lehtimaki, T
Laippala, P
Roytta, M
Viitanen, M
Wahlund, LO
Winblad, B
Lannfelt, L
Citation: Km. Mattila et al., Interaction between estrogen receptor 1 and the epsilon 4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women, NEUROSCI L, 282(1-2), 2000, pp. 45-48
Authors:
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Hinkka, SM
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study, J CEREBR B, 20(11), 2000, pp. 1604-1609
Authors:
Kaasinen, V
Vilkman, H
Hietala, J
Nagren, K
Helenius, H
Olsson, H
Farde, L
Rinne, JO
Citation: V. Kaasinen et al., Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain, NEUROBIOL A, 21(5), 2000, pp. 683-688
Authors:
Kaasinen, V
Ruottinen, HM
Nagren, K
Lehikoinen, P
Oikonen, T
Rinne, JO
Citation: V. Kaasinen et al., Upregulation of putaminal dopamine D-2 receptors in early Parkinson's disease: A comparative PET study with [C-11]raclopride and [C-11]N-methylspiperone, J NUCL MED, 41(1), 2000, pp. 65-70
Authors:
Bhatia, KP
Lee, MS
Rinne, JO
Revesz, T
Scaravilli, F
Davies, L
Marsden, CD
Citation: Kp. Bhatia et al., Corticobasal degeneration look-alikes, ADV NEUROL, 82, 2000, pp. 169-182
Authors:
Kemppainen, N
Ruottinen, H
Nagren, K
Rinne, JO
Citation: N. Kemppainen et al., PET shows that striatal dopamine D1 and D2 receptors are differentially affected in AD, NEUROLOGY, 55(2), 2000, pp. 205-209
Authors:
Kaasinen, V
Nagren, K
Hietala, J
Oikonen, V
Vilkman, H
Farde, L
Halldin, C
Rinne, JO
Citation: V. Kaasinen et al., Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease, NEUROLOGY, 54(7), 2000, pp. 1482-1487
Authors:
Aberg, L
Liewendahl, K
Nikkinen, P
Autti, T
Rinne, JO
Santavuori, P
Citation: L. Aberg et al., Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms, NEUROLOGY, 54(5), 2000, pp. 1069-1074